Consolidated Statements of Changes in Stockholders' Equity - USD ($)	Common Stock [Member]	Preferred Stock [Member]	Additional Paid-in Capital [Member]	Noncontrolling Interest [Member]	Retained Earnings [Member]	Total
Beginning balance, value at Dec. 31, 2019	$ 24,000		$ 115,560,000		$ (103,281,000)	$ 12,303,000
Beginning balance, shares at Dec. 31, 2019	1,206,000
Issuance of common stock, net	$ 68,000		20,127,000			20,195,000
Issuance of common stock, net, shares	3,434,000
Conversion of preferred stock	$ 13,000		(13,000)
Conversion of preferred stock, shares	663,000	(4,000)
Stock based payments, net of tax effect	$ 1,000		397,000			398,000
Stock based payments, net of tax effect, shares	50,000
Acquisition of Impact Biomedical, Inc.	$ 10,000	$ 1,000	38,309,000	3,911,000		42,231,000
Acquisition of Impact BioMedical, Inc., shares	483,000	47,000
Net (loss) income				(480,000)	1,899,000	1,419,000
Ending balance, value at Dec. 31, 2020	$ 116,000	$ 1,000	174,380,000	3,430,000	(101,382,000)	76,545,000
Ending balance, shares at Dec. 31, 2020	5,836,000	43,000
Issuance of common stock, net	$ 1,347,000		120,433,000			121,780,000
Issuance of common stock, net, shares	67,340,000
Conversion of preferred stock	$ 131,000	$ (1,000)	(130,000)
Conversion of preferred stock, shares	6,570,000	(43,000)
Stock based payments, net of tax effect			2,000			2,000
Stock based payments, net of tax effect, shares
Acquisition of American Pacific Bancorp				33,097,000		33,097,000
Acquisition of American Pacific Bancorp, shares
Acquisition of Sharing Services Global Corporation				803,000		803,000
Acquisition of Sharing Services Global Corporation, shares
Net (loss) income				(921,000)	(33,119,000)	(34,040,000)
Ending balance, value at Dec. 31, 2021	$ 1,594,000		$ 294,685,000	$ 36,409,000	$ (134,503,000)	$ 198,185,000
Ending balance, shares at Dec. 31, 2021	79,746,000